Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
- Resource Type
- Article
- Source
- The Lancet Diabetes & Endocrinology; November 2017, Vol. 5 Issue: 11 p864-876, 13p
- Subject
- Language
- ISSN
- 22138587; 22138595